Extracellular Matrix Market, By Component Type, By Application, By Source, By End-User, By Product Type, By Technology, By Therapeutic Area, By Function, By Biomaterial Type, By End-Use Industry, By Geography

Description

The extracellular matrix market size is expected to reach US$ 64.1 Mn by 2030, from US$ 37.9 Mn in 2023, at a CAGR of 7.8% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 37.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.80%	2030 Value Projection:	US$ 64.1 Mn

Figure 1. Extracellular Matrix Market Share (%), By Region, 2023

Extracellular matrix (ECM) refers to the complex network of proteins and carbohydrates that provide structural support to cells within tissues and organs. It plays a crucial role in regulating cell behavior, including cell adhesion, migration, proliferation, and differentiation. The ECM also acts as a reservoir for growth factors and cytokines, influencing various cellular processes. The global extracellular matrix market size is expected to grow significantly in the coming years due to rising incidences of chronic wounds, increasing aging population and growing incidence of road accidents. Extracellular matrix derived from human/animal tissues acts as a scaffold for cellular migration, proliferation and tissue organization. It promotes wound healing by stimulating cell proliferation, neovascularization and tissue remodeling. ECM technologies aim to recreate the complex structural and biochemical signals required for proper tissue regeneration and function. Promising clinical results in healing chronic wounds, combined with increasing preference for minimally invasive treatment options will boost demand for ECM products in the healthcare industry.

Market Dynamics:

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. The high cost of ECM-based therapies poses a significant barrier to market growth, limiting their accessibility to a larger patient population. Moreover, the stringent regulatory requirements for the approval of ECM-based products and the limited reimbursement policies in some regions hinder market expansion.

Additionally, the expansion of product portfolios in emerging markets, where the demand for regenerative medicine is growing, can open up new avenues for market growth.

In conclusion, the global extracellular matrix market is driven by factors such as the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. However, challenges such as high costs and regulatory requirements need to be addressed, while opportunities such as innovation and market expansion in emerging regions should be capitalized upon.

Key features of the study:

This report provides in-depth analysis of the global extracellular matrix market, including market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), with 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global virtual health service market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc., Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel GmbH, Tissue Regenix, Admedus, and MIMETAS.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, type upgrades, market expansion, and marketing tactics.
The global extracellular matrix market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracellular matrix market.

Extracellular Matrix Market Segmentation:

By Component Type
- Proteins
- Glycoproteins
- Proteoglycans
- Other ECM molecules
By Application:
- Regenerative Medicine
- Tissue Engineering
- Wound Healing
- Drug Delivery
- Others
By Source:
- Animal-Derived ECM
- Human-Derived ECM
- Synthetic ECM
By End-User:
- Research Institutes and Academic Centers
- Biotechnology and Pharmaceutical Companies
- Hospitals and Clinics
By Product Type:
- Hydrogels
- Scaffolds
- Decellularized ECM
- ECM Analogs
- Others
By Technology:
- 3D Bioprinting
- Nanotechnology
- Cell Culture Techniques
- Genetic Engineering
- Others
By Therapeutic Area:
- Orthopedics
- Dermatology
- Cardiology
- Neurology
- Oncology
- Others
By Function:
- Structural Support
- Cellular Communication
- Cell Adhesion
- Signal Transduction
By Biomaterial Type:
- Natural ECM
- Synthetic ECM
By End-Use Industry:
- Healthcare
- Research and Development
- Cosmetics
- Pharmaceuticals
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top companies in Extracellular Matrix Market
- Thermo Fisher Scientific
- DSM
- Acelity (KCI Concepts)
- Corning Incorporated
- Baxter
- FUJIFILM Holdings Corporation
- Integra LifeSciences
- CellSystems Biotechnologie Vertrieb GmbH
- Biotime, Inc.
- Trevigen, Inc.
- Advanced BioMatrix
- Collagen Matrix, Inc.
- Merck KGaA
- VWR International LLC
- REPROCELL USA Inc.
- BioLamina AB
- Matricel GmbH
- Tissue Regenix
- Admedus
- MIMETAS

Product Code: CMI6171

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Global Extracellular Matrix, By Component Type
- Market Global Extracellular Matrix, By Application
- Market Global Extracellular Matrix, By Source
- Market Global Extracellular Matrix, By End-User
- Market Global Extracellular Matrix, By Product Type
- Market Global Extracellular Matrix, By Technology
- Market Global Extracellular Matrix, By Therapeutic Area
- Market Global Extracellular Matrix, By Function
- Market Global Extracellular Matrix, By Biomaterial Type
- Market Global Extracellular Matrix, By End-Use Industry
- Market Global Extracellular Matrix, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
The increasing prevalence of chronic diseases
- Restraints
High cost of ECM-based therapies
- Opportunities
Development of innovative ECM-based products
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Extracellular Matrix Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Extracellular Matrix Market , By Component Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2018 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Glycoproteins
Proteoglycans
Other ECM molecules

6. Global Extracellular Matrix Market , By Application, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Tissue Engineering
Wound Healing
Drug Delivery
Cancer Research
Others

7. Global Extracellular Matrix Market , By Source, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Animal-Derived ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Human-Derived ECM
Synthetic ECM

8. Global Extracellular Matrix Market , By End-User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Research Institutes and Academic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Biotechnology and Pharmaceutical Companies
Hospitals and Clinics

9. Global Extracellular Matrix Market , By Product Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hydrogels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Scaffolds
Decellularized ECM
ECM Analogs
Others

10. Global Extracellular Matrix Market , By Technology, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
3D Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Nanotechnology
Cell Culture Techniques
Genetic Engineering
Others

11. Global Extracellular Matrix Market , By Therapeutic Area, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Orthopedics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Dermatology
Cardiology
Neurology
Oncology
Others

12. Global Extracellular Matrix Market , By Function, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Structural Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Cellular Communication
Cell Adhesion
Signal Transduction

13. Global Extracellular Matrix Market , By Biomaterial Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Natural ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Synthetic ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

14. Global Extracellular Matrix Market , By End-Use Industry, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Research and Development
Cosmetics
Pharmaceuticals
Others

15. Global Extracellular Matrix Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Function, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
U.S.
Canada
Europe
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
GCC
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa

16. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DSM
Acelity (KCI Concepts)
Corning Incorporated
Baxter
FUJIFILM Holdings Corporation
Integra LifeSciences
CellSystems Biotechnologie Vertrieb GmbH
Biotime, Inc.
Trevigen, Inc.
Advanced BioMatrix
Collagen Matrix, Inc.
Merck KGaA
VWR International LLC
REPROCELL USA Inc.
BioLamina AB
Matricel GmbH
Tissue Regenix
Admedus
MIMETAS
Analyst Views

17. Section

Research Methodology
About us